This policy fully supports the recommendations for clinical practice & training in transfusion medicine published by the National Institute of Health & Care Excellence (NICE), British Committee for Standards in Haematology (BCSH), the National Blood Transfusion Committee (NBTC), the Serious Hazards of Transfusion (SHOT) scheme & other national / local guidelines as referenced. This policy encompasses all blood components / products & has appendices covering guidance on specific issues.
Ashford & St Peters NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals.
Scope of the Policy
All staff involved in sampling, prescribing, ordering, collecting, administration of blood components / products & care/monitoring of a patient receiving a transfusion must read the sections relevant to their place of work & role.
This policy applies to adult patients at Ashford & St Peters NHS Foundation Trust and the satellite hospitals that use blood components/products supplied by the Transfusion Laboratories. At the time of writing this includes:
- Woking & Sam Beare Hospice
- BMI The Runnymede Hospital
- Walton Community Hospital
- Woking Community Hospital
The purpose of the policy is to assist all staff involved in any aspect of blood transfusion to ensure the right blood components / products are given to the right patient at the right time. It also aims to ensure a standardised approach to the management of patients receiving blood components / products, reflecting best practice, thereby reducing the risks associated with transfusions. The policy includes information on the use of specific components and products, and for the management of patients with specific needs (e.g. patients that refuse transfusions).
|Compiled by:||Dr J. De Vos, SPS Consultant Haematologist Lead for Transfusion
Nicola McVeagh, Lead Transfusion Practitioner
|Ratified by:||Senior Nursing and Midwifery Committee|
|Date Ratified:||July 2017|
|Date Issued:||February 2018|
|Review Date:||July 2020|
|Contact name:||Dr J. De Vos, Nicola McVeagh|